Bulletin: Minerva S.A. Ratings Not Immediately Affected By Announcement Of Potential Capital Injection - S&P Global Ratings’ Credit Research

Bulletin: Minerva S.A. Ratings Not Immediately Affected By Announcement Of Potential Capital Injection

Bulletin: Minerva S.A. Ratings Not Immediately Affected By Announcement Of Potential Capital Injection - S&P Global Ratings’ Credit Research
Bulletin: Minerva S.A. Ratings Not Immediately Affected By Announcement Of Potential Capital Injection
Published Dec 23, 2015
3 pages (1032 words) — Published Dec 23, 2015
Price Free  |  Buy this Report Now

About This Report

  
Abstract:

SAO PAULO (Standard&Poor's) Dec. 23, 2015--Standard&Poor's Ratings Services said today that its ratings and outlook on Minerva S.A. (global scale: BB-/Stable/--; national scale: brA/Stable/--) are not immediately affected following the recent announcement that Salic UK Ltd. can acquire up to 19.95% of Minerva's shares through a capital increase for Brazil-based protein producer. The transaction can add about R$750 million in cash to Minerva, bolstering its shareholders' equity and its already "strong" cash position. However, we expect this injection only to alleviate the pressures on the company's credit metrics, which have been somewhat weaker for our "aggressive" assessment of its financial risk profile. Despite Minerva's continued use of its free cash flow to reduce leverage, the approximate

  
Brief Excerpt:

...SAO PAULO (Standard & Poor's) Dec. 23, 2015--Standard & Poor's Ratings Services said today that its ratings and outlook on Minerva S.A. (global scale: ##-/Stable/--; national scale: brA/Stable/--) are not immediately affected following the recent announcement that Salic UK Ltd. can acquire up to 19.95% of Minerva's shares through a capital increase for Brazil-based protein producer. The transaction can add about R$750 million in cash to Minerva, bolstering its shareholders' equity and its already "strong" cash position. However, we expect this injection only to alleviate the pressures on the company's credit metrics, which have been somewhat weaker for our "aggressive" assessment of its financial risk profile. Despite Minerva's continued use of its free cash flow to reduce leverage, the approximate 50% depreciation of the Brazilian currency in 2015 has weighed on the company's metrics because the bulk of its debt is in foreign currency. Nevertheless, if the transaction is approved and occurs...

  
Report Type:

Bulletin

Ticker
BEEF3@BZ
Issuer
GICS
Packaged Foods & Meats (30202030)
Sector
Global Issuers, Structured Finance
Country
Region
Latin America
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Bulletin: Minerva S.A. Ratings Not Immediately Affected By Announcement Of Potential Capital Injection" Dec 23, 2015. Alacra Store. May 04, 2025. <http://www.alacrastore.com/s-and-p-credit-research/Bulletin-Minerva-S-A-Ratings-Not-Immediately-Affected-By-Announcement-Of-Potential-Capital-Injection-1556275>
  
APA:
S&P Global Ratings’ Credit Research. (). Bulletin: Minerva S.A. Ratings Not Immediately Affected By Announcement Of Potential Capital Injection Dec 23, 2015. New York, NY: Alacra Store. Retrieved May 04, 2025 from <http://www.alacrastore.com/s-and-p-credit-research/Bulletin-Minerva-S-A-Ratings-Not-Immediately-Affected-By-Announcement-Of-Potential-Capital-Injection-1556275>
  
Free
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Residential Mortgage-Backed Securities from one place.